Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Bracco U.K. Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, United Kingdom
E-Z-CAT 4.9% w/v oral suspension.
| Pharmaceutical Form |
|---|
|
Oral suspension. White, milky, viscous suspension. |
Active Constituent: Barium sulfate 4.9224% w/v (4.6% w/w).
Excipients with known effect:
Sorbitol, liquid (crystallising) (E420). Each 225 mL dose contains 16 g sorbitol.
Approximately 194 mg sodium per 225 mL dose.
Approximately 117 mg potassium per 225 mL dose.
Methyl parahydroxybenzoate (E218).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Barium sulfate |
Barium sulfate is inert and has no pharmacological action. It serves only as a radiopaque substance to opacify the gastro-intestinal tract during X-ray examinations. |
| List of Excipients |
|---|
|
Sorbitol, liquid (crystallising) (E420) |
High density polyethylene bottle with polypropylene screw-on cap with aluminium tamper-evident seal containing 225 mL.
Bracco U.K. Ltd, Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, United Kingdom
PL 18920/0028
15th May 1985 / 28th June 2001
| Drug | Countries | |
|---|---|---|
| E-Z-CAT | Ecuador, Estonia, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
